Literature DB >> 13240578

The use of reserpine in an open psychiatric setting.

G J SARWER-FONER, W OGLE.   

Abstract

Entities:  

Keywords:  MENTAL DISORDERS/therapy; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh:

Substances:

Year:  1955        PMID: 13240578      PMCID: PMC1826055     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Effects of largactil in mental syndromes.

Authors:  H AZIMA; W OGLE
Journal:  Can Med Assoc J       Date:  1954-08       Impact factor: 8.262

2.  Use of Rauwolfia serpentina Benth. in neuropsychiatric conditions.

Authors:  N S KLINE
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

  2 in total
  7 in total

1.  Recognition and management of drug-induced extra-pyramidal reactions and "paradoxical" behavioural reactions in psychiatry.

Authors:  G J SARWER-FONER
Journal:  Can Med Assoc J       Date:  1960-08-13       Impact factor: 8.262

2.  Clinical investigation of suvren; a new sedative preparation.

Authors:  G J SARWER-FONER; E K KORANYI; T E DANCEY
Journal:  Can Med Assoc J       Date:  1957-06-01       Impact factor: 8.262

3.  The clinical investigation of pacatal in open psychiatric settings.

Authors:  G J SARWER-FONER; E K KORANYI
Journal:  Can Med Assoc J       Date:  1957-09-01       Impact factor: 8.262

4.  Psychosis and enhanced anxiety produced by reserpine and chlorpromazine.

Authors:  G J SARWER-FONER; W OGLE
Journal:  Can Med Assoc J       Date:  1956-04-01       Impact factor: 8.262

5.  Depressive states and drugs. III. Use of methylphenidate (Ritalin) in open psychiatric settings and in office practice.

Authors:  A B KERENYI; E K KORANYI; G J SARWER-FONER
Journal:  Can Med Assoc J       Date:  1960-12-10       Impact factor: 8.262

6.  Depressive states and drugs. II. The study of phenelzine dihydrogen sulfate (nardil) in open psychiatric settings.

Authors:  G J SARWER-FONER; E K KORANYI; A MESZAROS; H GRAUER
Journal:  Can Med Assoc J       Date:  1959-12-15       Impact factor: 8.262

7.  Clinical investigation of trifluoperazine (stelazine) in open psychiatric settings.

Authors:  G J SARWER-FONER; E K KORANYI; J MACKAY; H GRAUER
Journal:  Can Med Assoc J       Date:  1959-11-01       Impact factor: 8.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.